Official registry condition

Prostate Adenocarcinoma peptide trials

5 selected ClinicalTrials.gov records carrying the official condition label Prostate Adenocarcinoma. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

5 selected records.

Connected peptides

3 profiles.

Registry update years

2017–2026 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases3

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses1

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 95 selected PubMed records and 27 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Prostate Adenocarcinoma unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT04037254

PeptideScanner retained ClinicalTrials.gov record NCT04037254 at 2026-11-16T17:31:07.936Z. Its registry update date was 2026-07-10, and PeptideScanner's reviewed identity mapping was gonadorelin.

PeptideScanner change date
November 16, 2026
Cited source date
July 10, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01731912

PeptideScanner retained ClinicalTrials.gov record NCT01731912 at 2026-11-15T21:52:09.579Z. Its registry update date was 2019-01-18, and PeptideScanner's reviewed identity mapping was degarelix.

PeptideScanner change date
November 15, 2026
Cited source date
January 18, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00170157

PeptideScanner retained ClinicalTrials.gov record NCT00170157 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-05-15, and PeptideScanner's reviewed identity mapping was leuprolide.

PeptideScanner change date
August 13, 2026
Cited source date
May 15, 2017
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →